Jacobus Pharmaceutical doesn't have a Phase 2 trial up and running, much less finishing a Phase 3 or filing for an NDA. Check on clinical trials.gov. AF was tring hard to manipulate CPRX so that he could cover his short.
They will certainly bring the pps up. Keep that in mind.
Agreed. Only a mid-stage trial... hasn't started Phase 3 yet... meanwhile its debt has been mounting.
I am new to this company and found its business and price per share irresistable. Just bought some yesterday and will buy more today.
Well said, iwonder, "GBSN is making money and on a high growth trajectory, plus there are many catalysts coming up. The dillution pain will pass and share price will bottom in short term. Buying more at the bottom is the way to go."